Karnataka, India's biotech hub, is the first stop for global and domestic biotech investment in the country. The state has the first mover advantage, with strong research capabilities, resource base, skilled manpower and government support creating an enabling environment for high growth.
Karnataka is the Biotech Capital of India, with over 60% of all biotechnology companies in India having a base in Bangalore and and driving 50% of the total revenues in the national biotechnology sector.
Karnataka's pharmaceutical sector exports 40% of the total pharma produce and accounts for 8% of the country's total pharma revenue.
Karnataka ranks 10th in the number of pharma manufacturing units in the country.
Presence of exclusive Biotechnology focused SEZs and India's largest biotech industry cluster.
Dedicated Biotechnology parks and centers planned such as Nutri/ Nutraceutical and Phyto-Pharmaceutical Park (N2P2) at Mysore, Marine Biotech Park at Mangalore, Agri Biotech Park at Dharwad, and Vivarium (Animal House) at Bidar.
Biotech Millennium Policy revamped in 2009 to meet evolving challenges.
State Industrial Policy 2009-14 creating industry specific zones, SEZs and parks
Four BT parks are being proposed and 3 SEZs in addition to the currently operational SEZ in Bangalore.
Special concessions for Mega Projects in biotechnology.
Government has provided special funds worth Rs 100 Crores for manufacturing and a Rs 50 Crore R&D corpus fund for biotech companies.
Bangalore: The Science Capital
Bangalore, Asia's fastest growing technopolis and world's fourth largest technology cluster is an ideal destination for biotechnology firms looking for specialized research faculties, medical and engineering graduates, IT support structure and modern infrastructure.
The state has biotech projects worth Rs. 150 million on offer, that have the potential of providing 8,000 jobs in this sector.
Indian Institute of Science (IISc)
Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)